Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.

<h4>Objectives</h4>Investigating the survival features, and determinants of treatment and stage at presentation in Iran.<h4>Methods</h4>461 patients with pancreatic ductal adenocarcinoma (PC) were prospectively enrolled from Shariati hospital, Tehran, Iran, between 2011-2018....

Full description

Bibliographic Details
Main Authors: Mahdi Sheikh, Sahar Masoudi, Razieh Bakhshandeh, Alireza Moayyedkazemi, Farhad Zamani, Sepideh Nikfam, Masoumeh Mansouri, Neda Ghamarzad Shishavan, Saman Nikeghbalian, Paul Brennan, Reza Malekzadeh, Akram Pourshams
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243511
id doaj-914a273b710f45eb8a6ed29cd286a578
record_format Article
spelling doaj-914a273b710f45eb8a6ed29cd286a5782021-03-04T12:55:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e024351110.1371/journal.pone.0243511Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.Mahdi SheikhSahar MasoudiRazieh BakhshandehAlireza MoayyedkazemiFarhad ZamaniSepideh NikfamMasoumeh MansouriNeda Ghamarzad ShishavanSaman NikeghbalianPaul BrennanReza MalekzadehAkram Pourshams<h4>Objectives</h4>Investigating the survival features, and determinants of treatment and stage at presentation in Iran.<h4>Methods</h4>461 patients with pancreatic ductal adenocarcinoma (PC) were prospectively enrolled from Shariati hospital, Tehran, Iran, between 2011-2018. All patients underwent endoscopic ultrasonography, computed tomography scanning, and physical examination. Validated questionnaire was completed for the participants and all were actively followed on monthly basis.<h4>Results</h4>Median survival time was 6.5 months, and 1-, and 5-year survival rates were 26.2%, and 1.5%. Patients who were older (p<0.001), illiterate (p = 0.004), unmarried (p = 0.003), rural inhabitant (p = 0.013), opium user (p = 0.039), and had lower body mass index (BMI) (p = 0.002) had lower overall survival. Tumors located in the head of pancreas were more commonly diagnosed at lower stages (p<0.001). Only 10.4% of patients underwent surgery who were more commonly educated (p<0.001), married (p = 0.005), had a tumor located in the head of pancreas (p = 0.016), and were diagnosed at lower stages (p<0.001). After adjustment for potential confounders and risk factors, rural inhabitance (HR: 1.33 (95% CI: 1.01-1.74)), having more symptoms (HR for each increasing symptom: 1.06 (1.02-1.11)), using opium (HR: 1.51 (1.04-2.20)), having a tumor located in the body of pancreas (HR: 1.33 (1.02-1.75)), and having an advanced tumor stage (HR: 2.07 (1.34-3.19)) remained significantly associated with increased risk of mortality. After the adjusting for potential confounders, we did not find significant relationships between smoking, alcohol intake, and BMI with the risk of death among patients with pancreatic cancer.<h4>Conclusions</h4>Iranian patients with PC have very poor long-term survival. Besides tumor's stage and location, socioeconomic disparities could affect the probabilities of receiving treatment and/or survival in these patients. Opium use is an independent risk factor for mortality among PC patients in Iran.https://doi.org/10.1371/journal.pone.0243511
collection DOAJ
language English
format Article
sources DOAJ
author Mahdi Sheikh
Sahar Masoudi
Razieh Bakhshandeh
Alireza Moayyedkazemi
Farhad Zamani
Sepideh Nikfam
Masoumeh Mansouri
Neda Ghamarzad Shishavan
Saman Nikeghbalian
Paul Brennan
Reza Malekzadeh
Akram Pourshams
spellingShingle Mahdi Sheikh
Sahar Masoudi
Razieh Bakhshandeh
Alireza Moayyedkazemi
Farhad Zamani
Sepideh Nikfam
Masoumeh Mansouri
Neda Ghamarzad Shishavan
Saman Nikeghbalian
Paul Brennan
Reza Malekzadeh
Akram Pourshams
Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
PLoS ONE
author_facet Mahdi Sheikh
Sahar Masoudi
Razieh Bakhshandeh
Alireza Moayyedkazemi
Farhad Zamani
Sepideh Nikfam
Masoumeh Mansouri
Neda Ghamarzad Shishavan
Saman Nikeghbalian
Paul Brennan
Reza Malekzadeh
Akram Pourshams
author_sort Mahdi Sheikh
title Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
title_short Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
title_full Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
title_fullStr Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
title_full_unstemmed Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
title_sort survival features, prognostic factors, and determinants of diagnosis and treatment among iranian patients with pancreatic cancer, a prospective study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description <h4>Objectives</h4>Investigating the survival features, and determinants of treatment and stage at presentation in Iran.<h4>Methods</h4>461 patients with pancreatic ductal adenocarcinoma (PC) were prospectively enrolled from Shariati hospital, Tehran, Iran, between 2011-2018. All patients underwent endoscopic ultrasonography, computed tomography scanning, and physical examination. Validated questionnaire was completed for the participants and all were actively followed on monthly basis.<h4>Results</h4>Median survival time was 6.5 months, and 1-, and 5-year survival rates were 26.2%, and 1.5%. Patients who were older (p<0.001), illiterate (p = 0.004), unmarried (p = 0.003), rural inhabitant (p = 0.013), opium user (p = 0.039), and had lower body mass index (BMI) (p = 0.002) had lower overall survival. Tumors located in the head of pancreas were more commonly diagnosed at lower stages (p<0.001). Only 10.4% of patients underwent surgery who were more commonly educated (p<0.001), married (p = 0.005), had a tumor located in the head of pancreas (p = 0.016), and were diagnosed at lower stages (p<0.001). After adjustment for potential confounders and risk factors, rural inhabitance (HR: 1.33 (95% CI: 1.01-1.74)), having more symptoms (HR for each increasing symptom: 1.06 (1.02-1.11)), using opium (HR: 1.51 (1.04-2.20)), having a tumor located in the body of pancreas (HR: 1.33 (1.02-1.75)), and having an advanced tumor stage (HR: 2.07 (1.34-3.19)) remained significantly associated with increased risk of mortality. After the adjusting for potential confounders, we did not find significant relationships between smoking, alcohol intake, and BMI with the risk of death among patients with pancreatic cancer.<h4>Conclusions</h4>Iranian patients with PC have very poor long-term survival. Besides tumor's stage and location, socioeconomic disparities could affect the probabilities of receiving treatment and/or survival in these patients. Opium use is an independent risk factor for mortality among PC patients in Iran.
url https://doi.org/10.1371/journal.pone.0243511
work_keys_str_mv AT mahdisheikh survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT saharmasoudi survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT raziehbakhshandeh survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT alirezamoayyedkazemi survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT farhadzamani survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT sepidehnikfam survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT masoumehmansouri survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT nedaghamarzadshishavan survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT samannikeghbalian survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT paulbrennan survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT rezamalekzadeh survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
AT akrampourshams survivalfeaturesprognosticfactorsanddeterminantsofdiagnosisandtreatmentamongiranianpatientswithpancreaticcanceraprospectivestudy
_version_ 1714801104713154560